Protean BioDiagnostics presents a new method to identify potential therapeutic targets in breast cancer.
The method called OncoSignal analysis utilizes mRNA transcriptional measurements to accurately calculate the pathway activity of seven key oncogenic signaling pathways.
Read MoreProtean BioDiagnostics is thrilled to be recognized by Orange County Mayor, Jerry L. Demings in his annual state of the County address on Jun 4th, 2021 at the Orlando convention center.
Read MoreProtean is pleased to announce that its below-referenced abstract has been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Virtual Annual Meeting.
Read MoreBreast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreBreast cancer screening tests, including mammograms, ultrasounds, and MRIs, were delayed as a result of the COVID-19 pandemic, according to studies presented at the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer.
Read MoreProtean BioDiagnostics has been featured in “Careers in The Corridor,” a spotlight on opportunities for high-skill, high-value careers across the 23-county Florida High Tech Corridor region.
Read More
